PERCEPTIVE ADVISORS LLC 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-31 4:16 pm Purchase |
2024-10-30 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 5,479,348 14.200% |
20,900 (+0.38%) |
Filing |
| 2023-12-29 5:15 pm Purchase |
2023-12-27 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 5,458,448 14.300% |
647,299 (+13.45%) |
Filing |
| 2022-07-01 4:45 pm Purchase |
2022-06-30 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 4,811,149 12.800% |
1,385,233 (+40.43%) |
Filing |
| 2021-02-08 5:16 pm Purchase |
2021-01-25 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 3,425,916 9.800% |
3,425,916 (New Position) |
Filing |